Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

fe4a0710-a6db-4735-9d1a-113df310def6

7fcd0a07-4d2f-5b33-a5e5-d130ea44aff7

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • INTERFERON_ALPHA_RESPONSE+0.400
  • PROTEIN_SECRETION+0.300
  • DNA_REPAIR+0.200
  • MITOTIC_SPINDLE+0.200
  • UNFOLDED_PROTEIN_RESPONSE+0.200
  • MYC_TARGETS_V2+0.100
  • OXIDATIVE_PHOSPHORYLATION+0.100
  • PI3K_AKT_MTOR_SIGNALING+0.100
  • E2F_TARGETS+0.000
  • G2M_CHECKPOINT+0.000

Top 10 suppressed

  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.600
  • ALLOGRAFT_REJECTION-0.500
  • APICAL_SURFACE-0.500
  • IL6_JAK_STAT3_SIGNALING-0.500
  • INFLAMMATORY_RESPONSE-0.500
  • KRAS_SIGNALING_UP-0.500
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.500
  • TNFA_SIGNALING_VIA_NFKB-0.500
  • ANGIOGENESIS-0.400
  • COAGULATION-0.400

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

8 twins match this tumor's tissue · 2 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR5088921
melanoma-umap@29
0.903
2SRR5088920
melanoma-umap@29
0.898
3MDT-AP-0329
medullo-epn-umap@date-based
MedMedulloblastoma0.892
4SRR2780299
melanoma-umap@29
0.859
5SRR1797246
lung-landscapes@6
cohortSC0.856
6SRR655864
brain-umap@2
GTEX0.853
7R337
bladder-landscape@3
0.853
8TCGA-A8-A06N-01A-11R-A00Z-07
breast-umap@18
B0.847
9MNG823
mng-umap@100
0.846
10SRR4195674
colon-landscapes@1
0.846

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 8 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
INTERFERON_ALPHA_RESPONSE0.400Inavolisib— uncovered
PROTEIN_SECRETION0.300Remibrutinib— uncovered
DNA_REPAIR0.200Idelalisib— uncovered
MITOTIC_SPINDLE0.200Inavolisib— uncovered
UNFOLDED_PROTEIN_RESPONSE0.200Idelalisib— uncovered
MYC_TARGETS_V20.100Idelalisib— uncovered
OXIDATIVE_PHOSPHORYLATION0.100Remibrutinib— uncovered
PI3K_AKT_MTOR_SIGNALING0.100Inavolisib— uncovered